The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management

Over the past decades, accumulating evidence has demonstrated a pivotal role of cholecystokinin type 2 receptor (CCK2R) in pain modulation. The established role of CCK2R activation in directly facilitating nociception has led to the development of several CCK2R antagonists, which have been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Amandine, Danigo, Aurore, Bourthoumieu, Sylvie, Mroué, Mohamad, Desmoulière, Alexis, Sturtz, Franck, Rovini, Amandine, Demiot, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618735/
https://www.ncbi.nlm.nih.gov/pubmed/34832967
http://dx.doi.org/10.3390/ph14111185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618735/
https://www.ncbi.nlm.nih.gov/pubmed/34832967
http://dx.doi.org/10.3390/ph14111185

Ejemplares similares